We fund and support clinical trials which seek to slow, stop or reverse Parkinson’s. Find out about the trials that are recruiting as part of our International Linked Clinical Trials (iLCT) programme developed in partnership with Van Andel Institute.

Please note: The current pandemic has slowed, and in some cases stopped, the recruitment process to these clinical studies. Each site will have guidelines and advice about their own COVID protocols.

The ADepT-PD trial (nortriptyline)

This trial is recruiting 408 people in 30 centres across the UK. Funded by the NIHR with support from Cure Parkinson’s, the trial lead is Professor Anette Schrag, the…

The AND-PD Trial

This study (ANxiety with or without depressive features in Parkinson’s Disease ‘AND-PD’) is an observational and imaging study where people at different stages of Parkinson’s will be assessed and…

The Anle138b Trial

This clinical trial is testing a small molecule called Anle138b to assess its potential to inhibit alpha-synuclein masses accumulating. In Parkinson’s, alpha-synuclein, which is abundant in nerve cells, begins clumping together (or aggregating) and…

The AZA-PD Trial (azathioprine)

Dr Williams-Gray’s team at the University of Cambridge’s Centre for Parkinson-Plus are conducting a clinical trial of azathioprine (AZA-PD), a medication already used to treat inflammation by dampening down the immune…

PD Frontline

As research has expanded in the area of Parkinson’s genetics, researchers have been able to uncover a number of genes which have been linked to an increased risk of…

The PROSEEK trial of KO706

Sun Pharma Advanced Research Company (SPARC) is conducting a phase 2 clinical trial to evaluate the safety and effectiveness of its experimental c-Abl inhibitor KO706 in people with early…

Other studies and surveys you might be interested in

Taking part in research is vital because it enables earlier, more accurate diagnoses, better predictions of future disease progression and more insight into the biology of the condition. Other studies, some of which are online, are recruiting participants now.

Find out more here